First Alzheimer’s anti-amyloid treatment receives full FDA approval
July 6 - It works by reducing amyloid plaques that form in the brain
July 6 - It works by reducing amyloid plaques that form in the brain
June 30 - Report offers new insights into science, research, regulation and more
June 26 - Safe disposal is one part of FDA’s effort to address overdose crisis
June 13 - Learn about program initiatives to drive rare disease drug development
June 12 - FC is a common condition experienced by children and adolescents
June 6 - Guidance ensures participant safety and reliability of clinical trials
PSAs inform consumers about the safe use and disposal of FDA-regulated products
The agency and HHS are working together to address the public health emergency
New initiative supports delivery of treatments for patients with a rare disease
Your source for the latest drug information.
Know the moment it happens.